Pingji Y. Liu
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Corrigendum to "Human umbilical cord-derived mesenchymal stem cells attenuate liver fibrosis by inhibiting hepatocyte ferroptosis through mitochondrial transfer" [Free Radic. Biol. Med. 231 (2025) 163-177].
Journal: Free radical biology & medicine
Published: December 06, 2025
Human umbilical cord-derived mesenchymal stem cells attenuate liver fibrosis by inhibiting hepatocyte ferroptosis through mitochondrial transfer.
Journal: Free radical biology & medicine
Published: October 06, 2024
Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1/GPX4-mediated ferroptosis in hepatic stellate cells.
Journal: Journal of nanobiotechnology
Published: October 01, 2024
Integrated Bioinformatics and Validation Reveal IFI27 and Its Related Molecules as Potential Identifying Genes in Liver Cirrhosis.
Journal: Biomolecules
Published: October 29, 2023
Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 13, 2023
Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.
Journal: International immunopharmacology
Published: July 20, 2023
Causal Relationship Between Gut Microbiota and Liver Cirrhosis: 16S rRNA Sequencing and Mendelian Randomization Analyses.
Journal: Journal of clinical and translational hepatology
Published: May 29, 2023
Advancements in mesenchymal stem cell therapy for liver cirrhosis: Unveiling origins, treatment mechanisms, and current research frontiers.
Journal: Tissue & cell
Published: April 27, 2023
Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism.
Journal: International immunopharmacology
Published: April 13, 2023
Hypertension and NAFLD risk: Insights from the NHANES 2017-2018 and Mendelian randomization analyses.
Journal: Chinese medical journal
Published: February 18, 2023
Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases.
Journal: Journal of gastroenterology and hepatology
Published: January 30, 2023
Last Updated: 09/26/2026